Salvina Therapeutics Email Formats

Biotechnology Research • c/o Switzerland Innovation Park Basel Area, Hegenheimermattweg 167A, Switzerland • 1-10 Employees

Key Contact at Salvina Therapeutics

Joseph Rapa

director owner

Company overview

Headquarters	c/o Switzerland Innovation Park Basel Area, Hegenheimermattweg 167A, Allschwil, 4123, CH
NAICS	541714
Keywords	Drug Development, Autoimmune Disease, Inflammatory Disease
Employees	1-10
Socials

About Salvina Therapeutics

Salvina Therapeutics has unlocked a novel approach for selectively targeting TNF and other TNF superfamily members, resulting in the generation of antibodies with a highly innovative mode of action. These have the potential to significantly improve the benefit/risk ratio of TNF targeting in certain diseases and enable bispecific therapies that have not been developable to date.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

Founder/Owner

Funding Data

Explore Salvina Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-11-02	9	$544,700

Funding Insights

$544,700

Total funding amount

$544,700

Most recent funding amount

Number of funding rounds

Frequently asked questions

Salvina Therapeutics is located in c/o Switzerland Innovation Park Basel Area, Hegenheimermattweg 167A, CH.

Salvina Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Salvina Therapeutics has raised a total of $544,700 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Salvina Therapeutics

Joseph Rapa

director owner

4.8

40,000 users